Both in R&D — Physical & Biological Sciences
OmniAb vs IB Acquisition
Over the past year OABI returned +268.8% and IBAC returned +3.7%; their daily moves had a correlation of -0.04.
OABI +268.8% IBAC +3.7%Growth of $1, one year, split-adjusted
| Metric | OABI | IBAC |
|---|---|---|
| Price | $5.18 | $10.81 |
| Market cap | $755.6M | $54.1M |
| Today | +0.58% | −0.46% |
| 1 month | +19.1% | −0.6% |
| 6 months | +262.2% | −0.2% |
| Year to date | +180.0% | +3.0% |
| 1 year | +250.0% | — |
| Revenue growth (YoY) | +78.3% | — |
| Gross margin | 92.3% | — |
| Net margin | −393.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 18.8× | — |
| Net cash | $64.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 71.6% | 20.1% |
| Short % of float | 9.7% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).